News Sentiment

SABS sentiment intelligence

SAB Biotherapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.82 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-2.6% over one week, +14.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 Assessment

Market Reaction

Balanced read

68/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction -2.6% Price reacting lower
Trend fit Trend inactive 14.7% over four weeks
Fair value -3.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 28
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 8
MarketBeat 6
TradingKey 3
MT Newswires 3
simplywall.st 3
Stock Titan 2
Insider Monkey 2

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 11
Analyst action 10
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-48 of 48